Animal Models to Study the Mutational Landscape for Oral Cavity and Oropharyngeal Cancers

Overview

Journal J Oral Maxillofac Res

Date 2014 Jan 15

PMID 24422024

Citations 4

Authors

Michael T Spiotto

Matthew Pytynia

Gene-Fu F Liu

Mark C Ranck

Ryan Widau

Affiliations

Soon will be listed here.

Abstract

Objectives: Cancer is likely caused by alterations in gene structure or expression. Recently, next generation sequencing has documented mutations in 106 head and neck squamous cell cancer genomes, suggesting several new candidate genes. However, it remains difficult to determine which mutations directly contributed to cancer. Here, summarize the animal models which have already validated and may test cancer causing mutations identified by next generation sequencing approaches.

Material And Methods: We reviewed the existing literature on genetically engineered mouse models and next generation sequencing (NGS), as it relates to animal models of squamous cell cancers of the head and neck (HNSCC) in PubMed.

Results: NSG has identified an average of 19 to 130 distinct mutations per HNSCC specimen. While many mutations likely had biological significance, it remains unclear which mutations were essential to, or "drive," carcinogenesis. In contrast, "passenger" mutations also exist that provide no selection advantage. The genes identified by NGS included p53, RAS, Human Papillomavirus oncogenes, as well as novel genes such as NOTCH1, DICER and SYNE1,2. Animal models of HNSCC have already validated some of these common gene mutations identified by NGS.

Conclusions: The advent of next generation sequencing will provide new leads to the genetic changes occurring in squamous cell cancers of the head and neck. Animal models will enable us to validate these new leads in order to better elucidate the biology of squamous cell cancers of the head and neck.

Citing Articles

RNAi-Mediated Knockdown of Cottontail Rabbit Papillomavirus Oncogenes Using Low-Toxicity Lipopolyplexes as a Paradigm to Treat Papillomavirus-Associated Cancers.

Ali U, Bette M, Ambreen G, Pinnapireddy S, Tariq I, Marquardt A Pharmaceutics. 2023; 15(10).

PMID: 37896139 PMC: 10610439. DOI: 10.3390/pharmaceutics15102379.

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.

Carper M, Troutman S, Wagner B, Byrd K, Selitsky S, Parag-Sharma K Cell Rep. 2019; 29(6):1660-1674.e7.

PMID: 31693903 PMC: 6870917. DOI: 10.1016/j.celrep.2019.10.005.

Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer.

Muhanna N, Di Grappa M, Chan H, Khan T, Jin C, Zheng Y Sci Rep. 2017; 7(1):16723.

PMID: 29196748 PMC: 5711859. DOI: 10.1038/s41598-017-17079-6.

Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy.

Kohli M, Wang L, Xie F, Sicotte H, Yin P, Dehm S PLoS One. 2015; 10(12):e0145176.

PMID: 26695660 PMC: 4687867. DOI: 10.1371/journal.pone.0145176.

References

Hanna E, Shrieve D, Ratanatharathorn V, Xia X, Breau R, Suen J . A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res. 2001; 61(6):2376-80. View

Scheffner M, Munger K, Byrne J, Howley P . The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci U S A. 1991; 88(13):5523-7. PMC: 51909. DOI: 10.1073/pnas.88.13.5523. View

Liu L, Schwartz S, Davis B, Gerson S . Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer. Cancer Res. 2002; 62(11):3070-6. View

Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S . A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature. 2011; 473(7346):230-3. PMC: 3093658. DOI: 10.1038/nature09999. View

Raimondi A, Molinolo A, Gutkind J . Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model. Cancer Res. 2009; 69(10):4159-66. DOI: 10.1158/0008-5472.CAN-08-4645. View

Singh B, Kim S, Carew J, Yu I, Shaha A, Wolden S . Genome-wide screening for radiation response factors in head and neck cancer. Laryngoscope. 2000; 110(8):1251-6. DOI: 10.1097/00005537-200008000-00005. View

Strati K, Pitot H, Lambert P . Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A. 2006; 103(38):14152-7. PMC: 1599927. DOI: 10.1073/pnas.0606698103. View

Brake T, Connor J, Petereit D, Lambert P . Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res. 2003; 63(23):8173-80. View

Donehower L, Harvey M, Slagle B, McArthur M, Montgomery Jr C, Butel J . Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356(6366):215-21. DOI: 10.1038/356215a0. View

10.

Lo K, Kwong J, Hui A, Chan S, To K, Chan A . High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res. 2001; 61(10):3877-81. View

11.

Bornstein S, White R, Malkoski S, Oka M, Han G, Cleaver T . Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest. 2009; 119(11):3408-19. PMC: 2769185. DOI: 10.1172/JCI38854. View

12.

Cowan J, Beckett M, Weichselbaum R . Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst. 1992; 84(10):793-7. DOI: 10.1093/jnci/84.10.793. View

13.

Loyo M, Li R, Bettegowda C, Pickering C, Frederick M, Myers J . Lessons learned from next-generation sequencing in head and neck cancer. Head Neck. 2012; 35(3):454-63. PMC: 3715072. DOI: 10.1002/hed.23100. View

14.

Jones J, Raval J, Beals T, Worsham M, Van Dyke D, Esclamado R . Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Identification of 2 regions of loss--18q11.1-q12.3 and 18q21.1-q23. Arch Otolaryngol Head Neck Surg. 1997; 123(6):610-4. DOI: 10.1001/archotol.1997.01900060052009. View

15.

Shin M, Pitot H, Lambert P . Pocket proteins suppress head and neck cancer. Cancer Res. 2012; 72(5):1280-9. PMC: 3293996. DOI: 10.1158/0008-5472.CAN-11-2833. View

16.

Chung C, Parker J, Karaca G, Wu J, Funkhouser W, Moore D . Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004; 5(5):489-500. DOI: 10.1016/s1535-6108(04)00112-6. View

17.

Song S, Gulliver G, Lambert P . Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc Natl Acad Sci U S A. 1998; 95(5):2290-5. PMC: 19323. DOI: 10.1073/pnas.95.5.2290. View

18.

Van Dyke D, Worsham M, Benninger M, Krause C, Baker S, Wolf G . Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer. 1994; 9(3):192-206. DOI: 10.1002/gcc.2870090308. View

19.

Strati K, Lambert P . Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res. 2007; 67(24):11585-93. PMC: 2859176. DOI: 10.1158/0008-5472.CAN-07-3007. View

20.

Stransky N, Egloff A, Tward A, Kostic A, Cibulskis K, Sivachenko A . The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333(6046):1157-60. PMC: 3415217. DOI: 10.1126/science.1208130. View